Key Challenges & Considerations in the Transition from Pre-clinical to FIH clinical studies in Neurologic indications

Time: 12:00 pm
day: Day One: Track B AM


The plan for this expert panel discussion is to focus on the challenges and considerations that companies face as the emerge from Discovery/Pre-clinical work and plan to enter First in Human (FIH) studies requiring support from their GMP manufacturing programs/partners, clinical development, and engagement with patient communities in the planning and early execution of clinical research.